OpenAI has recently experienced another executive departure, marking a significant moment in the company's structural changes, particularly since this individual was pivotal in managing their data center strategy.
Chris Malone, who previously held the position of head of data centers at OpenAI, departed from the company last week, according to a report by the Wall Street Journal. Before his time at OpenAI, Malone served nearly five years at Meta and over a decade at Google. He joined OpenAI in March 2022, making his time with the company notably brief.
Malone's arrival at OpenAI aligned closely with the inception of the Stargate Project — a substantial $500 million initiative aimed at enhancing U.S. data center capabilities, which received backing from the Trump administration. OpenAI is recognized as a significant partner in this venture, along with major players like Oracle, Nvidia, SoftBank, and Microsoft.
The reasons behind Malone's departure remain uncertain. Given the current surge in AI infrastructure development across the sector, the role of data center strategy has gained considerable attention, making his exit particularly unexpected.
OpenAI addressed Malone's departure in a statement to TechCrunch, explaining that they had "recently reorganized" their "infrastructure organization to better accommodate the scale and pace of our work." The company emphasized that they have a "strong, deeply experienced data center team" equipped with effective leadership and technical know-how to carry out their plans.
As part of the reorganization, Malone transitioned from reporting directly to OpenAI president Greg Brockman to reporting to VP Sachin Katti, who has now taken command of the group.
A range of other executives are currently involved in overseeing the data center strategy at OpenAI, including Uday Ruddarraju, who leads the data center team; Brent Mayo, who manages the building and delivery program; and Spas Lazarov, an experienced professional in the data center and energy fields, who heads all engineering efforts.
Malone's exit adds to a significant trend, as he is not the only executive to leave the company this year. Business Insider has noted a total of 13 departures, several of which occurred within the past month. Notably, these are senior-level positions rather than junior roles.
Recent changes have included the replacement of Chief Revenue Officer Denise Dresser, who served at OpenAI for only eight months. Just prior to her departure announcement, another senior executive, Brad Lightcap, who had been with the company for many years and acted as Chief Operating Officer, also announced his exit, hinting at new ventures ahead without providing further details.
A month earlier, the company also saw the departure of Fidji Simo, who had been acting as the second-in-command by heading product and business operations. She left her role to focus on recovering from a chronic illness, although she remains with OpenAI in an advisory capacity.
The organization has also seen important exits from its safety and ethics teams, including the departure of Chloé Bakalar, who was the head of ethics, and the disbandment of the preparedness team, responsible for evaluating the potential risks associated with the company’s AI models.
Other team leaders, such as Bill Peebles, the former head of the now-terminated AI image generator Sora, left after their projects were shut down. The company also saw its Chief Marketing Officer, Kate Rouch, exit in April over health concerns, similar to Simo.
Despite these developments, the remaining leadership has attempted to downplay the implications of these ongoing executive shifts. Co-founder Greg Brockman acknowledged that the heightened scrutiny on the company means each departure is analyzed more closely than might typically be the case.
This rapid turnover, however, has sparked considerable speculation, especially as OpenAI prepares for an anticipated IPO. The company's public offering, initially anticipated within this year, has now reportedly been pushed to 2027. As the company undergoes extensive reputational scrutiny, doubts about its valuation and profitability in relation to the massive investments being funneled into the lab have surfaced.
The wave of executive departures has certainly done little to alleviate these concerns.
